Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Express Scripts
Dow
Boehringer Ingelheim
McKesson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

AMPHETAMINE SULFATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Amphetamine Sulfate

A generic version of AMPHETAMINE SULFATE was launched as amphetamine sulfate by AMNEAL PHARMS on December 14th, 2019.

Drug patent expirations by year for AMPHETAMINE SULFATE
Drug Prices for AMPHETAMINE SULFATE

See drug prices for AMPHETAMINE SULFATE

Recent Clinical Trials for AMPHETAMINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Arbor Pharmaceuticals, Inc.Phase 3
Sarah MorrowPhase 2/Phase 3
Arbor Pharmaceuticals, Inc.Phase 4

See all AMPHETAMINE SULFATE clinical trials

Pharmacology for AMPHETAMINE SULFATE

US Patents and Regulatory Information for AMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 211139-001 Sep 26, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Lannett AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 083901-001 Aug 31, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 211639-002 Apr 17, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
Lannett AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 083901-002 Aug 31, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 211139-002 Sep 26, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 211639-001 Apr 17, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
Granules Pharms AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 212619-002 Aug 5, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Mallinckrodt
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.